Skip to main content
TipRanks
Go Ultimate75% OFF

Silence Therapeutics (SLN) Revenue

395 Followers

Silence Therapeutics Revenue

Silence Therapeutics had a revenue of 0.00 in the quarter ending Jun 30, 2026, with -100.00%. This bring the company's revenue in the last twelve months to 614.29K, Decreased 33.34%. In the fiscal year ending Dec 31, 2025, Silence Therapeutics had annual revenue of 559.00K with -98.71% growth.

Revenue (ttm)
614.29K
Revenue Growth
―
P/S Ratio
2200.41
Revenue/Employee
$6,352
Employees
88
Market Cap
$1.23B

Revenue Chart

Silence Therapeutics Revenue - Annual

010M20M30M40M50M16.00K244.00K5.48M12.41M17.65M25.38M43.26M559.00K201720182019202020212022202320242025
Revenue History
Download to Excel
SLN revenue history
Fiscal End DateRevenueChangeGrowth
Dec 31, 2025559.00K-42.70M-98.71%
Dec 31, 202443.26M17.88M70.47%
Dec 31, 202325.38M7.72M43.74%
Dec 31, 202217.65M5.24M42.19%
Dec 31, 202112.41M6.94M126.59%
Dec 31, 20205.48M5.24M2145.49%
Dec 31, 2019244.00K244.00K―
Dec 31, 20180.00-16.00K-100.00%
Dec 31, 201716.00K――
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Related stocks
CompanyRevenue
SLN614.29K
GALT0.00
ABEO39.01M
HUMA2.12M
VOR0.00